Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

692 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Patil SB, Tamirat M, Khazhidinov K, Ardizzoni E, Atger M, Austin A, Baudin E, Bekhit M, Bektasov S, Berikova E, Bonnet M, Caboclo R, Chaudhry M, Chavan V, Cloez S, Coit J, Coutisson S, Dakenova Z, De Jong BC, Delifer C, Demaisons S, Do JM, Dos Santos Tozzi D, Ducher V, Ferlazzo G, Gouillou M, Khan U, Kunda M, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moreau M, Moschioni M, Nahid P, Osso E, Oyewusi L, Panda S, Pâquet A, Thuong Huu P, Pichon L, Rich ML, Rupasinghe P, Salahuddin N, Sanchez Garavito E, Seung KJ, Velásquez GE, Vallet M, Varaine F, Yuya-Septoh FJ, Mitnick CD, Guglielmetti L. Patil SB, et al. Among authors: chaudhry m. Trials. 2023 Nov 30;24(1):773. doi: 10.1186/s13063-023-07701-6. Trials. 2023. PMID: 38037119 Free PMC article.
Re-evaluating the merits of decentralization as a core strategy for effective delivery of drug-resistant tuberculosis care in Pakistan.
Khan U, Lotia-Farrukh I, Akhtar A, Khowaja SN, Khan S, Madhani F, Parekh A, Adnan S, Ahmed S, Chaudhry M, Hussain H, Habib A, Butt S, Siddiqui MR, Ijaz R, Jamal S, Khan AB, Keshavjee S, Khan AJ, Salahuddin N, Khan PY. Khan U, et al. Among authors: chaudhry m. Health Policy Plan. 2022 Sep 13;37(8):979-989. doi: 10.1093/heapol/czac038. Health Policy Plan. 2022. PMID: 35527232 Free PMC article.
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).
Turner N, Saura C, Aftimos P, van den Tweel E, Oesterholt M, Koper N, Colleoni M, Kaczmarek E, Punie K, Song X, Armstrong A, Bianchi G, Stradella A, Ladoire S, Lim JSJ, Quenel-Tueux N, Tan TJ, Escrivá-de-Romaní S, O'Shaughnessy J; TULIP Trial Investigators. Turner N, et al. J Clin Oncol. 2024 Oct 23:JCO2400529. doi: 10.1200/JCO.24.00529. Online ahead of print. J Clin Oncol. 2024. PMID: 39442070
Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management.
Kattih Z, Bade B, Hatabu H, Brown K, Parambil J, Hata A, Mazzone PJ, Machnicki S, Guerrero D, Chaudhry MQ, Kellermeyer L, Johnson K, Cohen S, Ramdeo R, Naidich J, Borczuck A, Raoof S. Kattih Z, et al. Among authors: chaudhry mq. Chest. 2024 Oct 10:S0012-3692(24)05294-2. doi: 10.1016/j.chest.2024.09.033. Online ahead of print. Chest. 2024. PMID: 39393485 Review.
Interventions to Mitigate the Impact of COVID-19 Among People Experiencing Sheltered Homelessness: Chicago, Illinois, March 1, 2020-May 11, 2023.
Tietje L, Ghinai I, Cooper A, Tung EL, Borah B, Funk M, Ramachandran D, Gerber B, Man B, Singer R, Bell E, Moss A, Weidemiller A, Chaudhry M, Lendacki F, Bernard R, Gretsch S, English K, Huggett TD, Tornabene M, Cool C, Detmer WM, Schroeter MK, Mayer S, Davis E, Boegner J, Glenn EE, Phillips G 2nd, Falck S, Barranco L, Toews KA. Tietje L, et al. Among authors: chaudhry m. Am J Public Health. 2024 Oct;114(S7):S590-S598. doi: 10.2105/AJPH.2024.307801. Epub 2024 Aug 28. Am J Public Health. 2024. PMID: 39197136 Free PMC article.
692 results